About This Fund
Niremia Collective Fund I is a venture capital fund managed by Niremia Collective and closing at $22.5 million. This global fund aims to support innovative startups in the field of well-being technology with LPs including renowned domestic and international corporations and institutional investors, including Shionogi Pharmaceuticals, Mistletoe Venture Partners founded by investor Taizo Son, and MIXI Inc.
As of February 2024, the fund has invested in twelve well-being technology startups, including Feno, which offers AI-powered oral care services, TRIPP, a VR/XR wellness platform, and DeepWell, which specializes in mental health treatment using gaming.